Lorea Villanueva

837 citations
22 papers · 572 indexed · h-index 13
Topics
Immunotherapy and Immune Responses (9 papers)Advanced Breast Cancer Therapies (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)

In The Last Decade

Lorea Villanueva

21 papers receiving 561 citations

Peers

Lorea Villanueva
Comparison fields: 5 of 67
  • Immunology 275
  • Molecular Biology 261
  • Oncology 238
  • Cancer Research 70
  • Epidemiology 65
Replace Nourredine Himoudi with:
Nourredine Himoudi United Kingdom
Ursula R. Sorg Germany
Johannes Laengle Austria
Michael Fehlings Singapore
Maria Teresa Rodia Italy
Charlene Tow Singapore
T Meyer United Kingdom
D. Carbone United States
Iranzu González Spain
Derek Clouthier Canada
Lorea Villanueva relative to Nourredine Himoudi United Kingdom Nourredine Himoudi's profile →
Citations per field
00.5×4.6×
Nourredine Himoudi · 1×
Citations per year

Countries citing papers authored by Lorea Villanueva

Since Specialization
Citations

This map shows the geographic impact of Lorea Villanueva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorea Villanueva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorea Villanueva more than expected).

Fields of papers citing papers by Lorea Villanueva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorea Villanueva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorea Villanueva. The network helps show where Lorea Villanueva may publish in the future.

Co-authorship network of co-authors of Lorea Villanueva

This figure shows the co-authorship network connecting the top 25 collaborators of Lorea Villanueva. A scholar is included among the top collaborators of Lorea Villanueva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorea Villanueva. Lorea Villanueva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 1
4 4
5 2
6 1
7 18
8 21
9 155
10 15
11 23
12 116
13 1
14 40
15 16
16 52
17 3
18 15
19 22
20 43

About Lorea Villanueva

Lorea Villanueva is a scholar working on Immunology, Oncology and Hepatology, having authored 22 papers that have together received 572 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Immunology (275 citations), Oncology (238 citations) and Hepatology (41 citations). Lorea Villanueva has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Damiana Álvarez‐Errico, Manel Esteller, Juan José Lasarte, Pablo Sarobe, Marta Ruiz, Leyre Silva, Diana Llópiz, Teresa Lozano, Noëlia Casares and Bruno Sangro. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026